Exploration of 2D and 3D-QSAR analysis and docking studies for novel dihydropteridone derivatives as promising therapeutic agents targeting glioblastoma

Exploration of 2D and 3D-QSAR analysis and docking studies for novel dihydropteridone derivatives as promising therapeutic agents targeting glioblastoma

Background: Dihydropteridone derivatives represent a novel class of PLK1 inhibitors, exhibiting promising anticancer activity and potential as chemotherapeutic drugs for glioblastoma.Objective: The aim of this study is to develop 2D and 3D-QSAR models to validate the anticancer activity of dihydropt...

Full description

Bibliographic Details
Main Authors:	Meichen Pan, Lingxue Cheng, Yiguo Wang, Chunyi Lyu, Chao Hou, Qiming Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Pharmacology
Subjects:	glioblastoma drug design dihydropteridone derivatives QSAR molecule docking
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1249041/full

Similar Items

Quinazoline analogues as cytotoxic agents; QSAR, docking, and in silico studies
by: Leila Emami, et al.
Published: (2021-01-01)

QSAR modeling, molecular docking and molecular dynamic simulation of phosphorus-substituted quinoline derivatives as topoisomerase I inhibitors
by: Mouad Lahyaoui, et al.
Published: (2023-06-01)

Combined 3D-QSAR and Molecular Docking Analysis of Thienopyrimidine Derivatives as Staphylococcus aureus Inhibitors
by: Mebarka Ouassaf, et al.
Published: (2021-06-01)

QSAR ANALYSIS USING SEMI-EMPIRICAL AM1 METHOD, MOLECULAR DOCKING, AND ADMET STUDIES OF CHALCONE DERIVATIVES AS ANTIMALARIAL COMPOUNDS
by: Muhammad Akbar S Kurniawan, et al.
Published: (2023-12-01)

3D-QSAR and Docking Studies on Pyrimidine Derivatives of Second-Generation ALK Inhibitors
by: Gang-Long Jiang, et al.
Published: (2022-09-01)

Design of New Derivatives of Dimedone Molecules Using QSAR and Docking Molecular
by: Khaoula Mkhayar, et al.
Published: (2022-11-01)

3D-QSAR, docking and ADMET properties of aurone analogues as antimalarial agents
by: Hanine Hadni, et al.
Published: (2020-04-01)

In silico Studies Combining QSAR Models, DFT-based Reactivity Descriptors and Docking Simulations of Phthalimide Congeners with Hypolipidemic Activity
by: Camila da Câmara Lopes, et al.
Published: (2021-07-01)

Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancer
by: Yadav DK, et al.
Published: (2017-06-01)

QSAR modeling, molecular docking, dynamic simulation and ADMET study of novel tetrahydronaphthalene derivatives as potent antitubercular agents
by: Anguraj Moulishankar, et al.
Published: (2023-11-01)

2D-Quantitative structure activity relationship (QSAR) modeling, docking studies, synthesis and in-vitro evaluation of 1,3,4-thiadiazole tethered coumarin derivatives as antiproliferative agents
by: Natarajan Ramalakshmi, et al.
Published: (2021-07-01)

QSAR AND MOLECULAR DOCKING STUDY OF GONADOTROPIN-RELEASING HORMONE RECEPTOR INHIBITORS
by: David Ebuka Arthur, et al.
Published: (2022-09-01)

Design of new molecules against cervical cancer using DFT, theoretical spectroscopy, 2D/3D-QSAR, molecular docking, pharmacophore and ADMET investigations
by: Said El Rhabori, et al.
Published: (2024-02-01)

Combined 3D-QSAR, molecular docking and dynamics simulations studies to model and design TTK inhibitors
by: Noureen Ashraf, et al.
Published: (2022-11-01)

A Combination of 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation Studies of Benzimidazole-Quinolinone Derivatives as iNOS Inhibitors
by: Peixun Liu, et al.
Published: (2012-09-01)

Design, 3D-QSAR, molecular docking, ADMET, molecular dynamics and MM-PBSA simulations for new anti-breast cancer agents
by: Said El Rhabori, et al.
Published: (2024-06-01)

2D QSAR, design, docking study and ADMET of some N-aryl derivatives concerning inhibitory activity against Alzheimer disease
by: Abduljelil Ajala, et al.
Published: (2022-06-01)

Identify promising IKK-β inhibitors: A docking-based 3D-QSAR study combining molecular design and molecular dynamics simulation
by: Liang Li, et al.
Published: (2022-05-01)

Combined 3D-QSAR, molecular docking, ADMET, and drug-likeness scoring of novel diaminodihydrotriazines as potential antimalarial agents
by: Nedjla Khelfa, et al.
Published: (2024-06-01)

3D-ALMOND-QSAR Models to Predict the Antidepressant Effect of Some Natural Compounds
by: Speranta Avram, et al.
Published: (2021-09-01)

QSAR and molecular docking studies of isatin and indole derivatives as SARS 3CLpro inhibitors
by: Niousha Soleymani, et al.
Published: (2023-04-01)

In-silico design of new enalapril analogs (ACE inhibitors) using QSAR and molecular docking models
by: Jhon Alex Gonzalez Amaya, et al.
Published: (2020-01-01)

Computational studies of pyrimidine derivatives as inhibitors of human σ1 receptor using 3D-QSAR analysis, molecular docking, ADMET properties and DFT investigation
by: Maroua Fattouche, et al.
Published: (2024-06-01)

Computer-aided drug design of capuramycin analogues as anti-tuberculosis antibiotics by 3D-QSAR and molecular docking
by: Jin Yuanyuan, et al.
Published: (2017-12-01)

3D-QSAR Studies of Dihydropyrazole and Dihydropyrrole Derivatives as Inhibitors of Human Mitotic Kinesin Eg5 Based on Molecular Docking
by: Wenjuan Yang, et al.
Published: (2012-02-01)

Lipoxygenase Inhibition Activity of Coumarin Derivatives—QSAR and Molecular Docking Study
by: Melita Lončarić, et al.
Published: (2020-07-01)

QSAR, molecular docking, and design of novel 4-(N,N-diarylmethyl amines) Furan-2(5H)-one derivatives as insecticides against Aphis craccivora
by: Yusuf Isyaku, et al.
Published: (2020-03-01)

N-Phenyl Ureidobenzenesulfonate derivatives as novel anticancer agents: QSAR and Molecular docking studies
by: Masood Fereidoonnezhad, et al.
Published: (2017-05-01)

N-Phenyl Ureidobenzenesulfonate derivatives as novel anticancer agents: QSAR and Molecular docking studies
by: Masood Fereidoonnezhad, et al.
Published: (2017-06-01)

Design and Synthesis of Aminopyrimidinyl Pyrazole Analogs as PLK1 Inhibitors Using Hybrid 3D-QSAR and Molecular Docking
by: Swapnil P. Bhujbal, et al.
Published: (2022-09-01)

2D-QSAR, Docking, Molecular dynamics simulations with the MM/GBSA approaches against Grave's disease and PTPN22
by: Emmanuel Israel Edache, et al.
Published: (2023-08-01)

Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking
by: Guohui Sun, et al.
Published: (2016-06-01)

4D-QSAR: Perspectives in Drug Design
by: Carolina H. Andrade, et al.
Published: (2010-05-01)

Modeling of Re(I) tricarbonyl complexes against SARS-CoV-2 receptor via DFT, in-silico molecular docking, and QSAR
by: Ededet A. Eno, et al.
Published: (2022-12-01)

QSAR and molecular docking studies of novel 2,5-distributed-1,3,4-thiadiazole derivatives containing 5-phenyl-2-furan as fungicides against Phythophthora infestans
by: Yusuf Isyaku, et al.
Published: (2020-04-01)

Quantitative structure–activity relationship (QSAR) and molecular docking of xanthone derivatives as anti-tuberculosis agents
by: Emmy Yuanita, et al.
Published: (2020-12-01)

Molecular docking, 2D-QSAR and ADMET studies of 4-sulfonyl-2-pyridone heterocycle as a potential glucokinase activator
by: Prateek Sharma, et al.
Published: (2023-12-01)

Modelling the Anti-Methicillin-Resistant <em>Staphylococcus Aureus</em> (MRSA) Activity of Cannabinoids: A QSAR and Docking Study
by: Eliceo Cortes, et al.
Published: (2020-08-01)

Docking and QSAR of Aminothioureas at the SARS-CoV-2 S-Protein–Human ACE2 Receptor Interface
by: Wojciech Płonka, et al.
Published: (2020-10-01)

The novel 4-hydroxyphenylpyruvate dioxygenase inhibitors in vivo and in silico approach: 3D-QSAR analysis, molecular docking, bioassay and molecular dynamics
by: Juan Shi, et al.
Published: (2022-07-01)